Nanox (NASDAQ: NNOX), a medical imaging technology company, announced that its Nanox.ARC X digital tomosynthesis system has been named one of TIME's Best Inventions of 2026. The U.S. Food and Drug Administration-cleared system captures X-ray images from multiple angles, generating up to 200 coronal images per scan to produce three-dimensional views of the body at up to 80% less radiation than computed tomography (CT) for equivalent body parts. This recognition matters because it signals a potential shift in how medical imaging is delivered, with implications for cost, accessibility, and patient safety.
The Nanox.ARC X is designed with a smaller footprint than conventional CT systems and operates using a standard 110-volt power outlet. It features simplified installation, operator workflows, and remote upgrade capabilities. These attributes could allow the system to be deployed in settings where CT scanners are impractical, such as smaller clinics, rural hospitals, or mobile units. By reducing radiation exposure and infrastructure requirements, the technology may help expand access to advanced imaging, enabling earlier detection of disease and more efficient clinical workflows.
The company plans to showcase the system at the RSNA 2026 Annual Meeting in Chicago. This follows Nanox's previous special mention on TIME's Best Inventions of 2024 list for its artificial intelligence imaging solutions. The repeated recognition suggests that Nanox is making strides in integrating hardware, AI, and cloud-based services to create an end-to-end imaging platform.
Nanox's broader vision is to drive the world's transition to preventive health care by combining affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace. The Nanox ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX.
The implications of this announcement extend beyond a single product award. If Nanox.ARC X can deliver on its promise of lower radiation, reduced cost, and simplified deployment, it could disrupt the medical imaging market by making 3D imaging more accessible to a broader range of healthcare providers. This could lead to earlier diagnoses, better patient outcomes, and a more preventive-oriented healthcare system. For investors, the recognition by TIME may enhance Nanox's visibility and credibility, potentially attracting more attention to its stock and partnership opportunities.
MissionIR, a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN. It delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of social media followers, and a full array of tailored corporate communications solutions. For more information, please visit www.MissionIR.com.
